(Q35211961)

7 August 2017

1 reference

title

The efficacy and safety of terbinafine in children. (English)

1 reference

7 August 2017

0 references

Aditya K Gupta

1

0 references

Charles Lynde

series ordinal

3

object named as

Charles W Lynde

1 reference

7 August 2017

Elizabeth A Cooper

2

1 reference

7 August 2017

publication date

1 July 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

21

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

511-520

1 reference

Tinea capitis in California children: a population-based study of a growing epidemic

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Clinical pharmacokinetics of terbinafine (Lamisil).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Pharmacokinetics and pharmacology of terbinafine and itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Pharmacology of the allylamines

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Terbinafine: mode of action and properties of the squalene epoxidase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

In vitro activity of terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Effect of Terbinafine on the Pharmacokinetics of Cyclosporin in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Trichophyton tonsurans tinea capitis in the San Francisco Bay area: increased infection demonstrated in a 20-year survey of fungal infections from 1974 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophyte species

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Systemic antifungal treatment of children with terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Terbinafine (Lamisil) therapy for Microsporum canis scalp ringworm

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Oral terbinafine in tinea capitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Terbinafine pulse therapy is effective in tinea capitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Trichophyton tonsurans tinea capitis and tinea corporis: treatment and follow-up of four affected family members.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Onychomycosis in children: prevalence and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Antifungal therapy in children: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Onychomycosis in a 2-year-old child successfully treated with oral terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Treatment of childhood dermatophyte infections with oral terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Cutaneous 'ringworm' lesions of Scopulariopsis brevicaulis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Granulomatous skin infection caused by Scopulariopsis brevicaulis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Special features of the clinical use of oral terbinafine in the treatment of fungal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Oral terbinafine in the treatment of griseofulvin-resistant Tinea capitis et faciei et corporis in a 10-month-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Dermatophytosis of the scalp: incidence, immune response, and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Tinea capitis: asymptomatic carriage of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Treatment of symptom-free carriers in management of tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

Asymptomatic dermatophyte carriers in the households of children with tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2803%2900029-9

7 January 2021

10.1016/S0733-8635(03)00029-9

Identifiers

DOI

1 reference

7 August 2017

1 reference